Treatment choice in single-sided deafness and asymmetric hearing loss. A prospective, multicentre cohort study on 155 patients.

Mathieu Marx Isabelle MosnierChristophe VincentNicolas-Xavier BonneDavid BakhosEmmanuel LescanneJonathan FlamentDaniele BernardeschiOlivier SterkersBernard FraysseBenoit LepageBenoit GodeySébastien SchmerberAlain UzielMichel MondainFrédéric VenailOlivier Deguine

Published in: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2021)

More than one third of SSD/AHL subjects are unsatisfied after CROS and BCD trials. Repeated quality of life assessments help counselling the patient for his/her treatment choice.

Keyphrases

end stage renal disease
clinical trial
chronic kidney disease
ejection fraction
newly diagnosed
hearing loss
randomized controlled trial
prognostic factors
study protocol
combination therapy
decision making
hiv infected